Company Filing History:
Years Active: 2020-2025
Title: Erdem Karabulut: Innovator in Biocompatible Conductive Hydrogels
Introduction
Erdem Karabulut is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of biomedical engineering, particularly in the development of biocompatible conductive materials. With a total of 2 patents, his work focuses on innovative solutions for diagnostics and interventions in neurodegenerative and cardiac diseases.
Latest Patents
Karabulut's latest patents include the preparation and applications of biocompatible conductive 3D hydrogels based on cellulose nanofibrils. These hydrogels are designed for diagnostics and interventions to mimic or restore tissue and organ function. They can be extruded, cast, or injected, providing electrical conductivity in a wet form. The hydrogels can also be crosslinked using divalent ions, enhancing their mechanical stability. This invention has potential applications in drug screening for neurodegenerative diseases and in linking the human brain with electronic devices.
Another notable patent involves the preparation of biocompatible conductive inks based on cellulose nanofibrils for 3D printing of conductive biomedical devices. These inks allow for the creation of electrically conductive patterns that can be used to culture neural cells and study brain function. The devices created from these inks are also suitable for stimulating the heart and repairing myocardial infarction.
Career Highlights
Throughout his career, Karabulut has worked with various companies, including Cellheal AS and Ocean Tunicell AS. His innovative approaches have positioned him as a key figure in the development of advanced biomedical materials.
Collaborations
One of his notable collaborators is Paul Gatenholm, with whom he has worked on various projects related to biocompatible materials.
Conclusion
Erdem Karabulut's contributions to the field of biomedical engineering through his innovative patents and collaborations highlight his role as a leading inventor in the development of biocompatible conductive materials. His work has the potential to significantly impact the treatment of neurodegenerative and cardiac diseases.